Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
企業コードISRG
会社名Intuitive Surgical Inc
上場日Jun 13, 2000
設立日1995
最高経営責任者「CEO」Mr. David J. Rosa
従業員数15638
証券種類Ordinary Share
決算期末Jun 13
本社所在地1020 Kifer Road
都市SUNNYVALE
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号94086
電話番号14085232100
ウェブサイトhttps://www.intuitive.com/en-us/about-us/company
企業コードISRG
上場日Jun 13, 2000
設立日1995
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし